Clinical Trials Browser

Phase 1/2 × Glioblastoma × dactolisib × Clear all

NCT02430363 2016-02-24

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Phase 1/2 Unknown

Glioblastoma, Gliosarcoma